Arbutus Biopharma
ABUS
#6326
Rank
A$1.21 B
Marketcap
A$6.19
Share price
0.00%
Change (1 day)
23.51%
Change (1 year)

EPS for Arbutus Biopharma (ABUS)

EPS in 2025 (TTM): A-$0.40

According to Arbutus Biopharma 's latest financial reports the company's current EPS (TTM) is A-$0.36. In 2024 the company made an earnings per share (EPS) of A-$0.53 an increase over its 2023 EPS that were of A-$0.61.

EPS history for Arbutus Biopharma from 1998 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.40-25.01%
2024A-$0.53-13.64%
2023A-$0.61-4.35%
2022A-$0.64-44.58%
2021A-$1.16-17%
2020A-$1.40-65.4%
2019A-$4.04138.84%
2018A-$1.69-22.44%
2017A-$2.18-78.45%
2016A-$10.12424.64%
2015A-$1.93-20.19%
2014A-$2.4287.96%
2013A-$1.29-142.59%
2012A$3.02-342.7%
2011A-$1.24-25.82%
2010A-$1.6847.8%
2009A-$1.13-43.55%
2008A-$2.01158.91%
2007A-$0.78-111.88%
2006A$6.53-552.53%
2005A-$1.44-71.77%
2004A-$5.11-14.48%
2003A-$5.98-8.95%
2002A-$6.5770.07%
2001A-$3.8648.01%
2000A-$2.61-38.54%
1999A-$4.24-24.6%
1998A-$5.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
A-$0.08384-76.92% Bahamas
NRC Health
NRC
A$0.98-369.23%๐Ÿ‡บ๐Ÿ‡ธ USA